SMT201400035B - Composizioni comprendenti tramadol e celecoxib neltrattamento del dolore - Google Patents

Composizioni comprendenti tramadol e celecoxib neltrattamento del dolore

Info

Publication number
SMT201400035B
SMT201400035B SM201400035T SM201400035T SMT201400035B SM T201400035 B SMT201400035 B SM T201400035B SM 201400035 T SM201400035 T SM 201400035T SM 201400035 T SM201400035 T SM 201400035T SM T201400035 B SMT201400035 B SM T201400035B
Authority
SM
San Marino
Prior art keywords
celecoxib
compositions including
pain treatment
including tramadol
tramadol
Prior art date
Application number
SM201400035T
Other languages
English (en)
Italian (it)
Inventor
Salido Enrique Portillo
Ces Sebastia Videla
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201400035(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of SMT201400035B publication Critical patent/SMT201400035B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201400035T 2009-10-16 2014-03-20 Composizioni comprendenti tramadol e celecoxib neltrattamento del dolore SMT201400035B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09384004A EP2311446A1 (en) 2009-10-16 2009-10-16 Compositions comprising Tramadol and Celecoxib in the treatment of pain
PCT/EP2010/006317 WO2011045075A1 (en) 2009-10-16 2010-10-15 Compositions comprising tramadol and celecoxib in the treatment of pain

Publications (1)

Publication Number Publication Date
SMT201400035B true SMT201400035B (it) 2014-05-07

Family

ID=41566149

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400035T SMT201400035B (it) 2009-10-16 2014-03-20 Composizioni comprendenti tramadol e celecoxib neltrattamento del dolore

Country Status (33)

Country Link
US (3) US8569271B2 (enExample)
EP (3) EP2311446A1 (enExample)
JP (2) JP5579858B2 (enExample)
KR (1) KR101688996B1 (enExample)
CN (2) CN107050006A (enExample)
AR (1) AR078653A1 (enExample)
AU (1) AU2010306114B2 (enExample)
BR (1) BR112012005044B8 (enExample)
CA (1) CA2771651C (enExample)
CO (1) CO6511249A2 (enExample)
CY (1) CY1114960T1 (enExample)
DK (1) DK2488170T3 (enExample)
EC (1) ECSP12011735A (enExample)
ES (1) ES2450615T3 (enExample)
HR (1) HRP20140157T1 (enExample)
IL (1) IL218096A (enExample)
IN (1) IN2012DN01434A (enExample)
MA (1) MA33743B1 (enExample)
MX (1) MX2012003051A (enExample)
MY (1) MY156275A (enExample)
NZ (1) NZ598361A (enExample)
PL (1) PL2488170T3 (enExample)
PT (1) PT2488170E (enExample)
RS (1) RS53202B (enExample)
RU (2) RU2012120087A (enExample)
SG (1) SG178833A1 (enExample)
SI (1) SI2488170T1 (enExample)
SM (1) SMT201400035B (enExample)
TN (1) TN2012000059A1 (enExample)
TW (1) TWI466668B (enExample)
UA (1) UA108213C2 (enExample)
WO (1) WO2011045075A1 (enExample)
ZA (1) ZA201202151B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
US8746719B2 (en) * 2010-08-03 2014-06-10 Polaris Industries Inc. Side-by-side vehicle
EP2694048B1 (en) * 2011-04-05 2020-10-07 Optosolve Research & Development Ltd Ophthalmic treatments
PT2811833E (pt) * 2012-02-06 2015-12-07 William L Pridgen Associação de famciclovir e celecoxib para síndromes somáticas funcionais
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
JP6605047B2 (ja) * 2015-05-28 2019-11-13 ドクター・レディーズ・ラボラトリーズ・リミテッド 疼痛治療のためのセレコキシブの経口用組成物
KR101710792B1 (ko) * 2015-07-14 2017-02-28 주식회사 유영제약 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
MX2016006464A (es) * 2016-05-18 2017-11-17 Laboratorios Liomont S A De C V Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
BR112018074486A2 (pt) * 2016-05-27 2019-05-28 Dr Reddy´S Laboratories Ltd composição oral de celecoxib para tratamento da dor
WO2018186650A2 (ko) * 2017-04-03 2018-10-11 주식회사 킴스헬스케어 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제
US20200323780A1 (en) * 2017-04-03 2020-10-15 Kims Healthcare Co., Ltd. Bilayer combination tablet for oral administration containing tramadol and celecoxib
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
CA3137381A1 (en) * 2019-05-14 2020-11-19 Esteve Pharmaceuticals, S.A. Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadol
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途
CN114681470A (zh) 2020-12-28 2022-07-01 雷迪博士实验室有限公司 治疗疼痛的方法
WO2025125888A1 (en) * 2023-12-15 2025-06-19 Centro De Investigación Y De Estudios Avanzados Del I.P.N. Aripiprazole and tramadol compositions with potentiation effects and high analgesic efficacy useful for the treatment of neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516803A (en) 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
NZ513924A (en) 1999-03-01 2001-09-28 Ortho Mcneil Pharm Inc Composition comprising a tramadol material and a selective cox-2 inhibitor drug
DE19927688A1 (de) 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
PT1478366E (pt) * 2002-02-19 2009-03-10 Adcock Ingram Ltd Combinações farmacêuticas de meloxicam, fosfato de codeína e paracetamol
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
JP5399564B2 (ja) 2009-10-16 2014-01-29 ラボラトリオス・デル・デエレ・エステベ・エセ・ア トラマドールとコキシブとの共結晶
EP2392319A1 (en) 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Also Published As

Publication number Publication date
BR112012005044A2 (pt) 2016-05-03
WO2011045075A1 (en) 2011-04-21
HK1173379A1 (en) 2013-05-16
TN2012000059A1 (en) 2013-09-19
NZ598361A (en) 2014-01-31
IN2012DN01434A (enExample) 2015-06-05
RU2016125895A3 (enExample) 2018-12-05
US20150150889A1 (en) 2015-06-04
EP2737898A1 (en) 2014-06-04
AU2010306114A1 (en) 2012-03-15
JP5579858B2 (ja) 2014-08-27
US20140024622A1 (en) 2014-01-23
CY1114960T1 (el) 2016-12-14
EP2311446A1 (en) 2011-04-20
BR112012005044B8 (pt) 2021-05-25
DK2488170T3 (en) 2014-03-03
ES2450615T3 (es) 2014-03-25
CN107050006A (zh) 2017-08-18
TWI466668B (zh) 2015-01-01
SG178833A1 (en) 2012-05-30
IL218096A0 (en) 2012-04-30
AU2010306114B2 (en) 2015-07-23
TW201114418A (en) 2011-05-01
MX2012003051A (es) 2012-05-29
ECSP12011735A (es) 2012-05-30
JP2013507408A (ja) 2013-03-04
MY156275A (en) 2016-01-29
KR20120089287A (ko) 2012-08-09
RU2707752C2 (ru) 2019-11-29
UA108213C2 (uk) 2015-04-10
JP2014221797A (ja) 2014-11-27
US8569271B2 (en) 2013-10-29
EP2488170B1 (en) 2014-01-22
CN102573824A (zh) 2012-07-11
ZA201202151B (en) 2012-11-28
AR078653A1 (es) 2011-11-23
PL2488170T3 (pl) 2014-05-30
SI2488170T1 (sl) 2014-04-30
CO6511249A2 (es) 2012-08-31
PT2488170E (pt) 2014-03-11
IL218096A (en) 2015-02-26
MA33743B1 (fr) 2012-11-01
CA2771651A1 (en) 2011-04-11
KR101688996B1 (ko) 2016-12-22
RU2012120087A (ru) 2013-11-27
BR112012005044B1 (pt) 2020-12-15
US20120172341A1 (en) 2012-07-05
CA2771651C (en) 2016-08-23
RU2016125895A (ru) 2018-12-05
EP2488170A1 (en) 2012-08-22
HRP20140157T1 (hr) 2014-03-28
RS53202B (sr) 2014-06-30

Similar Documents

Publication Publication Date Title
DK3460056T3 (da) Terapeutiske nukleasesammensætninger og fremgangsmåder
ZA201202151B (en) Compositions comprising tramadol and celecoxib in the treatment of pain
DK2771041T3 (da) Sammensætninger og anvendelse deraf ved knogleheling
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI1011587A2 (pt) compostos e composições terapèuticas
DK2419732T3 (da) Prionfrie nanopartikelsammensætninger og fremgangsmåder
EP3957283C0 (en) TREATMENT OF OBESITY
IL218212A0 (en) Therapeutic methods and compositions
BR112012007861A2 (pt) dispositivos médicos e suas bombas
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
EP3381471C0 (en) PAIN TREATMENT
DK3363437T3 (da) Aminoindanforbindelser og anvendelse deraf i behandling af smerte
ZA201304353B (en) Remedial composition and treatment methods
SI2341900T1 (sl) Medicinski proizvod in zdravljenje
ZA201105125B (en) Hair treatment composition
IL209220A0 (en) Plant extract and its therapeutic use
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
BR112012004701A2 (pt) compostos e composições para tratamento do câncer
BRPI1013903A2 (pt) tratamentos terapêuticos utilizando centaquina
PL2375912T3 (pl) Kompozycje i sposoby leczenia uczucia dyskomfortu gardła
ZA201201116B (en) Hair treatment composition
ZA201203286B (en) Therapeutic and diagnostic applications against trypanosomosis
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
GB2473735B (en) Skin treatment formulation
GB0820562D0 (en) Novel use and treatment